KI NutriCare to Acquire Allergy Research Group (ALRG.OB) for $1.33 per Share in an All-Cash Tender Offer Valued At Approximately $19.5 Million
Source: http://Blog.QualityStocks.net/?p=11695Posted on Tuesday, August 12th, 2008 | In Market Commentary, OTCBB Markets, Small & Micro Cap, Stocks to Watch
Allergy Research Group, Inc. (OTCBB: ALRG), an innovative leader in nutraceutical research and product formulation, recently announced that the company and KI NutriCare, a wholly-owned subsidiary of Kikkoman Corporation (Toronto: 2801.TO), have entered into a definitive agreement for KI NutriCare to acquire Allergy Research Group for $1.33 per share or approximately $19.5 million. This acquisition, to be completed through Longhorn Acquisition Corp., is expected to accelerate KI NutriCare’s expansion in the nutritional supplement industry.
Under the terms of the agreement, Longhorn Acquisition Corp. will commence a cash tender offer to acquire all of the outstanding shares of Allergy Research Group common stock for $1.33 per share in cash. Following the acquisition, Longhorn Acquisition Corp. will be merged into Allergy Research Group, and the combined entity will become a wholly owned subsidiary of KI NutriCare.
Originally founded by Dr. Stephen A. Levine in 1979, Allergy Research Group, through its wholly-owned subsidiary, Nutricology Inc., focuses on the production and distribution of high-quality nutritional supplement products. Dr. Levine will continue to provide services to the combined entity as a consultant. Manfred Salomon, the current president of Allergy Research Group, will also continue to serve the combined entity as its chief operating officer.
Let us hear your thoughts below:
Last 5 posts by QualityStocks
- Novavax, Inc. (NVAX) Prices Offering Of Common Stock - November 24th, 2009
- Freshwater Technologies (FWTC.OB) Water Activation Technology Increases the Germination of Vegetable Crops - November 24th, 2009
- AlumniFuel Power Corp. (AFPW.OB) Subsidiary Turns Heads with Technology at Naval Energy Forum - November 24th, 2009
- Provectus Pharmaceuticals Inc. (PVCT.OB) Delivers Favorable Oncology Treatment; Presents Data to 3rd World Meeting of Interdisciplinary Melanoma/Skin Cancer Centers - November 24th, 2009
- TapImmune, Inc. (TPIV.OB) Among the Winners in the Booming Vaccine Business - November 24th, 2009
 About QualityStocks (http://QualityStocks.net)
Our name, QualityStocks, emphasizes our commitment to connect subscribers with companies that have huge potential to succeed in the short and long-term future. We believe strong management and vision for the future are crucial for any company to be successful. Timing is everything and we help investors succeed by providing an objective, broad-based view of the SmallCap markets on a daily basis. Please see disclaimer on QualityStocks website: http://disclaimer.qualitystocks.net |
No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.